SHERWIN WILLIAMS CO

Sherwin-Williams (SHW) reported record 2024 financial results and increased its dividend by 10.5% [2], [8]. However, Q1 2025 guidance fell short of expectations, leading to a stock decline [5]. UBS lowered its price target for SHW, anticipating a difficult earnings cycle due to increased upstream costs and weaker demand [3]. Concerns were also raised about underwhelming organic revenue growth, low future sales projections, and declining free cash flow margin [4]. While the company amended its credit agreement, demonstrating a focus on long-term financial health [2], insider selling activity has raised some concerns [6]. Upcoming Q1 2025 results will be released on April 29th [9].